Genitourinary Cancer
Conference Coverage
Moving on up: Maintenance therapy extends OS in bladder cancer
Conference Coverage
Active cancer increases death risk in patients with COVID-19
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
News from the FDA/CDC
FDA approves olaparib for certain metastatic prostate cancers
News
Oncologists’ income and satisfaction are up
From the Journals
Advanced prostate cancers still rising in U.S.
News from the FDA/CDC
First PARP inhibitor approved for metastatic prostate cancer
Conference Coverage
Video coaching may relieve anxiety and distress for long-distance cancer caregivers
Conference Coverage
ASCO goes ahead online, as conference center is used as hospital
From the Journals
Androgens may explain male vulnerability to COVID-19
From the Journals
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.